A breakthrough treatment for breast cancer patients has been approved. Two studies, both set to be released Wednesday, support more aggressive treatment of prostate cancer. A long-term cancer prevention study has yielded some startling results. It appears non-melanoma skin cancer has been linked with a greater risk for numerous other kinds of cancers. The first in a wave of gene-based attacks on cancer took a major step forward Wednesday as government scientists recommended that the drug, Herceptin, be sold to fight advanced breast cancer.
Scientists believe they have discovered an indicator of the two types of prostate cancers.
A new study suggests women at high risk of hereditary ovarian cancer can cut their chances of getting the disease in half by taking birth control pills. People put sunscreen on their faces, arms and legs but at times leave their lips unprotected. A cervical cancer vaccine is in the works. Herceptin is believed to provide a new medical breakthrough in fighting breast cancer.